The company has approval from the State Drug Control Authority to manufacture various Active Pharmaceuticals Ingredients. Presently the Company is engaged in manufacturing the following APIs keeping in view the market demand:


  1. Guaifenesin USP/BP/EP/IP
  2. Methocarbamol USP
  3. Phenazopyridine Hcl USP
  4. Fluconazole EP/USP
  5. Metformin Hcl IP/BP/USP
  6. Ambroxol Hcl IP/BP
  7. Melitracen Hcl

Therapeutic Category

  • Expectorant, (Mucolyte).
  • Relaxant (skeletal muscle relaxant)
  • Urinary tract analgesic
  • Anti-Fungal
  • Anti-Diabetic
  • Expectorant, (Mucolyte)
  • Antidepressant and Anxiolytic

Guaifenesin,This drug is used as a mucolyte. The respiratory conditions such as bronchitis, bronchial, asthma, emphysema, bronchospasm, bronchiectasis results in “increasing the viscosity of the mucus". This drug reduces the viscosity and increases the secretions of the respiratory tract and used in most of the cough expectorant in combination with other drugs.

Methocarbamol, This is a non-narcotic, non-toxic drug and is preferred in treating conditions like spasm and pain associated with acute musculoskeletal disorders, tension, myalgia, acute traumatic muscle spasm, acute disc prolapse, painful shoulder syndrome etc.

Phenazopyridine Hydrochloride, This drug has a specific local analgesic effect in the urinary tract, promptly relieving burning & pain and gives symptomatic relief of dysuria

Fluconazole, This drug is a bis-triazole anti fungal and widely used for treatment of fungal infections. Used in oral preparations, infections and as a cream

Metformin Hcl, This drug is non-insulin anti-diabetic. Since diabetes is growing in epidemic proportion in Asian Markets, the growth potential for this product in domestic and export is quite enormous.

Ambroxol Hcl This drug is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus.

Melitracen Hydrochloride – Melitracen Hydrochloride is a tricyclic antidepressant with actions and effects similar to amitriptyline. Melitracen Hydrochloride is given orally in the treatment of depression. It should be withdrawn gradually to reduce the risk of withdrawal symptoms.